[BrainScope has] an objective, accurate capability that can rapidly help identify and categorize patients with even the mildest forms of brain injury could help save lives, reduce radiation exposure, and decrease costs to the healthcare system. The performance and clinical utility of the Ahead 100 is superior to that of standard of practice tools. ~ Dr. J. Stephen Huff, Associate Professor of Emergency Medicine and Neurology at the University of Virginia School of Medicine and the Clinical Principal Investigator of the B-AHEAD II Trial in the article below
Posted on: Thu, 20 Nov 2014 01:30:06 +0000
Trending Topics
Recently Viewed Topics
© 2015